Free Trial

Life Science REIT (LON:LABS) Issues Quarterly Earnings Results

Life Science REIT logo with Real Estate background

Life Science REIT (LON:LABS - Get Free Report) released its quarterly earnings data on Wednesday. The company reported GBX 1.70 ($0.02) EPS for the quarter, Digital Look Earnings reports. Life Science REIT had a negative return on equity of 14.53% and a negative net margin of 198.99%.

Life Science REIT Stock Performance

Shares of LABS stock traded down GBX 0.10 ($0.00) during trading hours on Friday, reaching GBX 44 ($0.59). The company had a trading volume of 139,482 shares, compared to its average volume of 940,340. The business has a fifty day moving average price of GBX 40.11 and a 200-day moving average price of GBX 38.80. Life Science REIT has a one year low of GBX 31.30 ($0.42) and a one year high of GBX 47.10 ($0.63). The firm has a market cap of £156.21 million, a PE ratio of -3.90 and a beta of 0.08.

Life Science REIT Company Profile

(Get Free Report)

Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.

See Also

Should You Invest $1,000 in Life Science REIT Right Now?

Before you consider Life Science REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Life Science REIT wasn't on the list.

While Life Science REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines